Literature DB >> 8922364

The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets.

M Noda1, M Komatsu, G W Sharp.   

Abstract

betaHC-9 is a pancreatic beta-cell line that is derived from the hyperplastic islets of transgenic mice that express the simian virus 40 tumor antigen gene in the islets. This cell secretes insulin in response to glucose in a concentration-dependent manner. Maximal and half-maximal concentrations were approximately 20 and approximately 10 mmol/l, respectively, with a maximal fractional release that averaged 3.7% of the total cellular insulin content per 60 min. The cellular insulin content was 3-9% of the content of mouse islet cells. Under perifusion conditions, high glucose concentrations induced a sharp first phase that lasted approximately 10 min and a succeeding second phase of sustained release, as exhibited by mouse islets. The cells did not show a rising second phase as seen with rat islets. This biphasic response was obtained without the need for activators of protein kinase A such as forskolin or 3-isobutyl-1-methylxanthine. The dose-dependency and the phasic response to glucose were essentially invariable up to passage 38 but thereafter declined. The cells respond to various well-known stimulators of insulin secretion, including leucine and arginine; to modulators such as carbachol, glucagon-like peptide I, and pituitary adenylyl cyclase activating polypeptide; and to the inhibitors norepinephrine, somatostatin, and galanin. The pharmacological agents glibenclamide, 12-O-tetradecanoylphorbol-13-acetate, and KCl stimulate and forskolin potentiates insulin release. Mannoheptulose, 2-deoxyglucose, and nitrendipine inhibit glucose-stimulated insulin release from the cells. The intracellular Ca2+ concentration was raised by high glucose and by glibenclamide. In conclusion, this cell line preserves the fundamental characteristics of the progenitor normal mouse islets very well. Although several cell lines have been reported to have glucose-responsive insulin secretion, few demonstrate clear biphasic secretion as this cell line displays. In this context, this cell line should serve as a potent tool for studying the mechanisms of insulin secretion, especially the important phasic secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922364     DOI: 10.2337/diab.45.12.1766

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  Enhanced activation of phospholipase C and insulin secretion from islets incubated in fatty acid-free bovine serum albumin.

Authors:  Walter S Zawalich; Kathleen C Zawalich
Journal:  Metabolism       Date:  2008-02       Impact factor: 8.694

2.  Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).

Authors:  C V Burke; C W Buettger; E A Davis; S J McClane; F M Matschinsky; S E Raper
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 3.  Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins.

Authors:  Zhanxiang Wang; Debbie C Thurmond
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

4.  Biphasic insulin secretion from freshly isolated or cultured, perifused rodent islets: comparative studies with rats and mice.

Authors:  Walter S Zawalich; Hanae Yamazaki; Kathleen C Zawalich
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

5.  Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion.

Authors:  Satsuki Miyazaki; Fumi Tashiro; Takashi Tsuchiya; Kazuki Sasaki; Jun-Ichi Miyazaki
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.